Clinical Trial

HL-300 Ointment in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety and tolerability of HL-300 ointment following single and multiple topical administrations in healthy Chinese adult volunteers.
Trial Details
NCT Number NCT07684937
Lead Sponsor Hangzhou Highlightll Pharmaceutical Co., Ltd
Conditions Atopic Dermatitis
Enrollment 36 participants
Start Date 2024-06-14
Primary Completion 2024-11-25 (estimated)
Study Completion 2024-11-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-06